P. Braam, J. Roesink, C. Raaijmakers, W. Busschers, and C. Terhaard, Quality of life and salivary output in patients with head-and-neck cancer 5 years after radiotherapy

L. Devoize and D. R. Salivation, EMC-Chirurgie orale et maxillo-faciale

B. Pellat, Salives et milieu buccal EMC-Chirurgie orale et maxillo-faciale

C. Dawes, Salivary flow patterns and the health of hard and soft oral tissues, The Journal of the American Dental Association, vol.139, pp.18-24, 2008.
DOI : 10.14219/jada.archive.2008.0351

B. Thivichon-prince and J. Keller, Immunité du parodonte, EMC-Médecine Buccale, vol.7, issue.6, 2012.

T. Vuotila, L. Ylikontiola, T. Sorsa, H. Luoto, R. Hanemaaijer et al., The relationship between MMPs and pH in whole saliva of radiated head and neck cancer patients, Journal of Oral Pathology and Medicine, vol.31, issue.6
DOI : 10.1034/j.1600-0714.2002.310603.x

T. Sorsa, K. Suomalainen, and V. J. Uitto, The role of gingival crevicular fluid and salivary interstitial collagenases in human periodontal diseases, Archives of Oral Biology, vol.35, pp.193-196, 1990.
DOI : 10.1016/0003-9969(90)90156-5

T. Fábián, P. Hermann, A. Beck, P. Fejérdy, and G. Fábián, Salivary Defense Proteins: Their Network and Role in Innate and Acquired Oral Immunity, International Journal of Molecular Sciences, vol.26, issue.4, pp.4295-4320, 2012.
DOI : 10.1034/j.1600-051X.1999.261004.x

J. Égéa, C. Hirtz, J. Valcarcel, and D. Périère, Le facteur de croissance ??pidermique??: un gardien potentiel de la sant?? oro-digestive, Pathologie Biologie, vol.50, issue.10, pp.608-612, 2002.
DOI : 10.1016/S0369-8114(02)00357-7

C. Ortholan, K. Benezery, R. Bensadoun, C. Murdoch-kinch, N. Russo et al., Dose de tolérance à l'irradiation des tissus sains : les glandes salivaires Recovery of salivary epidermal growth factor in parotid saliva following parotid sparing radiation therapy: a proof-of-principle study, Cancer Radiothérapie janv, vol.4111, issue.131, pp.290-2946470, 2010.

S. Benomar, S. Boutayeb, I. Lalya, H. Errihani, B. Hassam et al., Traitement et pr??vention des radiodermites aigu??s, Cancer/Radioth??rapie, vol.14, issue.3, pp.213-216, 2010.
DOI : 10.1016/j.canrad.2010.02.001

D. Citrin, Y. Hitchcock, E. Chung, J. Frandsen, M. Urick et al., Determination of cytokine protein levels in oral secretions in patients undergoing radiotherapy for head and neck malignancies The correlation between epidermal growth factor levels in saliva and the severity of oral mucositis during oropharyngeal radiation therapy, Radiat Oncol Lond Engl. 26 avr Cancer. 1 déc, vol.789, issue.11, p.225865, 2000.

H. Dumbrigue, P. Sandow, K. Nguyen, and M. Humphreys-beher, Salivary epidermal growth factor levels decrease in patients receiving radiation therapy to the head and neck, Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, vol.89, issue.6
DOI : 10.1067/moe.2000.106343

M. Hannig, E. Dounis, T. Henning, N. Apitz, and L. Stösser, Does irradiation affect the protein composition of saliva?, Clinical Oral Investigations, vol.25, issue.1, p.7106615, 2000.
DOI : 10.1016/0360-3016(93)90143-J

T. Makkonen, J. Tenovuo, P. Vilja, A. Heimdahl, U. Funegård et al., Parotid saliva composition during and after irradiation of head and neck cancer Proteins and peptides in parotid saliva of irradiated patients compared to that of healthy controls using SELDI-TOF-MS Major salivary gland function in patients with radiation-induced xerostomia: flow rates and sialochemistry Minor gland saliva flow rate and proteins in subjects with hyposalivation due to Sjögren's syndrome and radiation therapy, al. Salivary BPIFA1 (SPLUNC1) and BPIFA2 (SPLUNC2 A) are modified by head and neck cancer radiotherapy M, et al. Differences in the whole saliva baseline proteome profile associated with development of oral mucositis in head and neck cancer patients undergoing radiotherapy, pp.2705-222303639, 1986.

T. Dijkema, C. Terhaard, J. Roesink, C. Raaijmakers, P. Van-den-keijbus et al., MUC5B levels in submandibular gland saliva of patients treated with radiotherapy for head-and-neck cancer: A pilot study, Radiation Oncology, vol.7, issue.1, p.91, 2012.
DOI : 10.1093/glycob/5.8.733

J. Stevens, J. Yepes, M. Randall, M. Kudrimoti, J. Feddock et al., Analysis of factors influencing the development of xerostomia during intensity-modulated radiotherapy

T. Himi, Y. Kukuminato, H. Kita, I. Yoshioka, and A. Kataura, Effect of radiotherapy on the levels of secretory immunoglobulin A against indigenous and virulent streptococci, Otolaryngology - Head and Neck Surgery, vol.117, issue.5
DOI : 10.1016/S0194-5998(97)70010-X

-. Otolaryngol, M. Wikstrom, and J. Groenink, Lactoferrin, amylase and mucin MUC5B and their relation to the oral microflora in hyposalivation of different origins, Neck Surg Off J Am Acad Otolaryngol-Head Neck Surg. nov Oral Microbiol Immunol. dec, vol.11716, issue.56, pp.345-52, 1997.

L. Tjäderhane, H. Larjava, T. Sorsa, V. Uitto, M. Larmas et al., The Activation and Function of Host Matrix Metalloproteinases in Dentin Matrix Breakdown in Caries Lesions Protein and mucin retention on oral mucosal surfaces in dry mouth patients European journal of oral sciences, J Dent Res. août, vol.77118, issue.11, pp.16229-33245, 1998.

C. Alliende, Reduced sulfation of muc5b is linked to xerostomia in patients with Sjogren syndrome, Annals of the Rheumatic Diseases, vol.67, issue.10, pp.1480-1487, 2008.
DOI : 10.1136/ard.2007.078246

D. Miricescu, M. Greabu, A. Totan, A. Didilescu, ?. Ra et al., The antioxidant potential of saliva: clinical significance in oral diseases, Therapeutics Pharmacology and Clinical Toxicology, vol.15, issue.2, pp.139-143, 2011.

C. Miller, J. Foley, A. Bailey, C. Campell, R. Humphries et al., Current developments in salivary diagnostics Expression of metalloproteinases 2 and 9 and tissue inhibitors 1 and 2 as predictors of lymph node metastases in oropharyngeal squamous cell carcinoma, Biomark Med. 1 févr, vol.437, issue.13, p.418422, 2010.